NasdaqGM:ATRCMedical Equipment
AtriCure (ATRC) Turns Q4 Profit And Tests Bullish Earnings Growth Narratives
AtriCure (ATRC) just posted its FY 2025 numbers with Q4 revenue of US$140.5 million and basic EPS of US$0.04 on net income of US$1.8 million, while on a trailing twelve month basis the company remains loss making with basic EPS at US$0.24 and net income of US$11.4 million. The company has seen quarterly revenue move from US$124.3 million in Q4 2024 to US$140.5 million in Q4 2025. Over the same periods, basic EPS shifted from a loss of US$0.33 to a small profit of US$0.04. This sets up a story...